Robert Kim
2023
In 2023, Robert Kim earned a total compensation of $4M as Chief Medical Officer at 4D Molecular Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $232,268 |
|---|---|
| Option Awards | $3,260,107 |
| Salary | $456,075 |
| Other | $16,500 |
| Total | $3,964,950 |
Kim received $3.3M in option awards, accounting for 82% of the total pay in 2023.
Kim also received $232.3K in non-equity incentive plan, $456.1K in salary and $16.5K in other compensation.
Rankings
In 2023, Robert Kim's compensation ranked 191st out of 2,937 executives tracked by ExecPay. In other words, Kim earned more than 93.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 191 out of 2,937 | 94th |
Division Manufacturing | 102 out of 1,622 | 94th |
Major group Chemicals And Allied Products | 66 out of 904 | 93rd |
Industry group Drugs | 65 out of 867 | 93rd |
Industry Biological Products, Except Diagnostic Substances | 22 out of 211 | 90th |
Source: SEC filing on April 10, 2024.
Kim's colleagues
We found two more compensation records of executives who worked with Robert Kim at 4D Molecular Therapeutics in 2023.